IP Library Granted Patent US 10,100,356
Granted Patent B2
US 10,100,356 · App. 14/859,725 · Granted Oct 16, 2018

Systems and methods for automated reusable parallel biological reactions

Inventors: Hesaam Esfandyarpour (Redwood City, CA); Mark F. Oldham (Emerald Hills, CA); Kosar Baghbani Parizi (Los Altos, CA); Eric S. Nordman (Palo Alto, CA)
Assignee: GENAPSYS, INC.
C12Q1/6874B01L3/502738B01L3/502761B01L7/52B03C1/286B03C1/288B03C1/30B03C5/005B03C5/022B03C5/026C12Q1/6848C12Q1/6853C12Q1/6869G01N1/40G01N27/4145G01N27/4146G01N33/5438B01L2200/0652B01L2200/0668B01L2200/0689B01L2200/10B01L2300/0645B01L2300/089B01L2300/0816B01L2300/0887B01L2300/12B01L2300/123B01L2400/043B01L2400/0415B01L2400/0418B01L2400/0421B01L2400/0424B01L2400/0427B01L2400/0478B01L2400/0655B03C2201/26C40B60/10G01N2001/4038
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,100,356
App. No.
14/859,725
Granted
Oct 16, 2018
Kind
B2
Abstract

A method comprises magnetically holding a bead carrying biological material (e.g., nucleic acid, which may be in the form of DNA fragments or amplified DNA) in a specific location of a substrate, and applying an electric field local to the bead to isolate the biological material or products or byproducts of reactions of the biological material. For example, the bead isolated from other beads having associated biological material. The electric field in various embodiments concentrates reagents for an amplification or sequencing reaction, and/or concentrates and isolates detectable reaction by-products. For example, by isolating nucleic acids around individual beads, the electric field can allow for clonal amplification, as an alternative to emulsion PCR. In other embodiments, the electric field isolates a nanosensor proximate to the bead, to facilitate detection of at least one of local pH change, local conductivity change, local charge concentration change and local heat. The beads may be trapped in the form of an array of localized magnetic field regions.

Claims (22)

1. A system, comprising:

at least one electrode that applies an electric field that concentrates or isolates molecules to each of a plurality of particles, wherein said plurality of particles are coupled to a biological species; and

a substantially planar sensor array adjacent to or downstream of said at least one electrode, wherein said substantially planar sensor array comprises a plurality of sensors comprising electrodes that are each (i) separate from said at least one electrode and (ii) in contact with a solution comprising said plurality of particles, wherein said plurality of sensors senses biological interaction events between said molecules and said biological species, and wherein said plurality of sensors senses said biological interaction events between said molecules and said biological species within Debye lengths of said plurality of particles or said plurality of sensors when said plurality of particles is disposed adjacent to said plurality of sensors.

2. The system of claim 1 , wherein said biological species are nucleic acid molecules and said biological interaction events are nucleic acid incorporation events, and wherein in (b), said plurality of sensors sense said nucleic acid incorporation events during sequencing of said nucleic acid molecules.

3. The system of claim 2 , further comprising a separation module upstream of said substantially planar sensor array, wherein said separation module separates particles among the plurality of particles that have nucleic acid molecules bound to or associated with the particles from particles that do not have nucleic acid molecules bound to or associated with the particles.

4. The system of claim 2 , further comprising a fragmentation module upstream of said substantially planar sensor array, wherein said fragmentation module (i) fragments nucleic acid molecules to generate nucleic acid fragments and (ii) binds or associates the nucleic acid fragments with the plurality of particles.

5. The system of claim 1 , wherein said biological species are proteins or antibodies.

6. The system of claim 1 , wherein said substantially planar sensor array is downstream of said at least one electrode.

7. The system of claim 1 , further comprising a magnetic array that is part of or adjacent to said planar sensor array, wherein said magnetic array provides a magnetic field to position an individual particle among said plurality of particles at a given position on the magnetic array.

8. The system of claim 1 , wherein the substantially planar sensor array does not contain wells.

9. The system of claim 1 , wherein an individual sensor of said substantially planar sensor array comprises two electrodes that measure an impedance of an individual particle among said plurality of particles during said biological interaction events.

10. The system of claim 1 , wherein the plurality of sensors measure changes in at least one of (i) a charge associated with, or a change in, the Debye length of a surface of an individual sensor among said plurality of sensors, (ii) a charge associated with the Debye length or a change in the Debye length of an individual particle among said plurality of particles, (iii) and a charge associated with the Debye length or a change in the Debye length of nucleic acid molecules carried on said individual particle.

11. The system of claim 7 , wherein said at least one electrode is a part of said magnetic array.

12. The system of claim 11 , wherein said at least one electrode is positioned such that said electric field is disposed around said magnetic field at said given position on said magnetic array.

13. The system of claim 7 , wherein said given position on said magnetic array comprises an individual sensor of said plurality of sensors.

14. The system of claim 1 , further comprising a plurality of signal amplifiers coupled to said plurality of sensors.

15. The system of claim 1 , wherein said at least one electrode is coupled to a microfluidic channel.

16. The system of claim 9 , wherein said two electrodes of said individual sensor are separated by a dielectric.

17. The system of claim 1 , wherein said at least one electrode is a pair of electrodes that apply said electric field.

18. The system of claim 1 , wherein said plurality of sensors is in contact with a solution having said plurality of particles coupled to said biological species.

19. The system of claim 1 , wherein said substantially planar sensor array is a two-dimensional array.

20. The system of claim 1 , wherein said at least one electrode comprises a corrosion resistant metal, noble metal, noble metal alloy, or carbon.

Assignments (7)
SECURITY INTEREST Recorded Jun 30, 2023
From: SEQUENCING HEALTH, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 064180/0928 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2022
From: GENAPSYS, INC.
To: SEQUENCING HEALTH, INC.
Reel/Frame 062128/0440 →
RELEASE OF SECURITY INTEREST Recorded Jan 26, 2021
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: GENAPSYS, INC.
Reel/Frame 055107/0633 →
SECURITY INTEREST Recorded Jun 25, 2020
From: GENAPSYS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 053053/0088 →
RELEASE OF SECURITY INTEREST Recorded Jul 17, 2019
From: OXFORD FINANCE LLC
To: GENAPSYS, INC.
Reel/Frame 049782/0910 →
SECURITY INTEREST Recorded Feb 6, 2019
From: GENAPSYS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 048257/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2015
From: ESFANDYARPOUR, HESAAM; PARIZI, KOSAR BAGHBANI; OLDHAM, MARK; NORDMAN, ERIC S.
To: GENAPSYS, INC.
Reel/Frame 036821/0892 →
Continuity (6)
Division 13824129
Provisional Application 61389484 · Oct 4, 2010
Provisional Application 61389490 · Oct 4, 2010
Provisional Application 61443167 · Feb 15, 2011
Provisional Application 61491081 · May 27, 2011
Related Publication 20160076097A1 · Mar 17, 2016